Infinite Genomics
Clinical molecular diagnostic laboratory providing RT-PCR–based testing and a menu of targeted molecular panels for infectious disease, pharmacogenomics, and pathology services. Operates a high-complexity laboratory with rapid turnaround (hours to 48 hours), web-based result delivery and EMR connectivity, specimen logistics services, and collaborations for assay development and research.
Industries
Nr. of Employees
small (1-50)
Infinite Genomics
North Little Rock, Arkansas, United States, North America
Products
UTI Pathogen Panel
Infinite Genomics’ InGenDX UTI Panel offers results in as little as 12 hours allowing you to make informed medical decisions quickly with results for a broad range of pathogens and potential antibiotic resistance.
UTI Pathogen Panel
Infinite Genomics’ InGenDX UTI Panel offers results in as little as 12 hours allowing you to make informed medical decisions quickly with results for a broad range of pathogens and potential antibiotic resistance.
Services
Rapid molecular testing panel for urinary tract infections that detects a broad range of pathogens and resistance markers; results available in as little as 12 hours after specimen receipt.
Multiplex molecular panel for acute respiratory infections enabling simultaneous detection of multiple respiratory pathogens and resistance markers with typical turnaround 24–48 hours.
Molecular testing for wound infections that detects and quantifies pathogens and resistance genes to support targeted antibiotic selection; typical turnaround 24–48 hours.
Molecular panel for gynecologic and genitourinary infections that detects multiple pathogens and resistance genes, with regional susceptibility context and EMR-accessible results.
Molecular diagnostic panel for sexually transmitted infections with high-specificity detection and the ability to detect multiple pathogens from a single specimen; results typically within 24 hours.
Molecular testing for nail fungal and other nail infections with specialized diagnostic options and turnaround typically 24–48 hours; integrates regional susceptibility and treatment guidance.
Rapid molecular testing panel for urinary tract infections that detects a broad range of pathogens and resistance markers; results available in as little as 12 hours after specimen receipt.
Multiplex molecular panel for acute respiratory infections enabling simultaneous detection of multiple respiratory pathogens and resistance markers with typical turnaround 24–48 hours.
Molecular testing for wound infections that detects and quantifies pathogens and resistance genes to support targeted antibiotic selection; typical turnaround 24–48 hours.
Molecular panel for gynecologic and genitourinary infections that detects multiple pathogens and resistance genes, with regional susceptibility context and EMR-accessible results.
Molecular diagnostic panel for sexually transmitted infections with high-specificity detection and the ability to detect multiple pathogens from a single specimen; results typically within 24 hours.
Molecular testing for nail fungal and other nail infections with specialized diagnostic options and turnaround typically 24–48 hours; integrates regional susceptibility and treatment guidance.
Expertise Areas
- Molecular diagnostics
- Infectious disease diagnostics
- Pharmacogenomics
- Clinical microbiology
Key Technologies
- Reverse-transcriptase PCR (RT-PCR)
- Multiplex PCR for polymicrobial detection
- Genetic marker-based resistance detection
- Pharmacogenomic genotyping